Jump to content

ALS2: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Citation bot (talk | contribs)
Add: bibcode. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 970/3626
m MOS:TM / convert special characters found by Wikipedia:Typo Team/moss (via WP:JWB)
 
(One intermediate revision by one other user not shown)
Line 26: Line 26:
*{{cite journal | author=Devon RS |title=The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings |journal=Clin. Genet. |volume=64 |issue= 3 |pages= 210–5 |year= 2004 |pmid= 12919135 |doi=10.1034/j.1399-0004.2003.00138.x | name-list-style=vanc | author2=Helm JR | author3=Rouleau GA | display-authors=3 | last4=Leitner | first4=Y | last5=Lerman-Sagie | first5=T | last6=Lev | first6=D | last7=Hayden | first7=MR |s2cid=27423316 }}
*{{cite journal | author=Devon RS |title=The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings |journal=Clin. Genet. |volume=64 |issue= 3 |pages= 210–5 |year= 2004 |pmid= 12919135 |doi=10.1034/j.1399-0004.2003.00138.x | name-list-style=vanc | author2=Helm JR | author3=Rouleau GA | display-authors=3 | last4=Leitner | first4=Y | last5=Lerman-Sagie | first5=T | last6=Lev | first6=D | last7=Hayden | first7=MR |s2cid=27423316 }}
*{{cite journal | author=Yamanaka K |title=Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 26 |pages= 16041–6 |year= 2004 |pmid= 14668431 |doi= 10.1073/pnas.2635267100 | pmc=307689 | name-list-style=vanc | author2=Vande Velde C | author3=Eymard-Pierre E | display-authors=3 | last4=Bertini | first4=E | last5=Boespflug-Tanguy | first5=O | last6=Cleveland | first6=DW |doi-access=free }}
*{{cite journal | author=Yamanaka K |title=Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 26 |pages= 16041–6 |year= 2004 |pmid= 14668431 |doi= 10.1073/pnas.2635267100 | pmc=307689 | name-list-style=vanc | author2=Vande Velde C | author3=Eymard-Pierre E | display-authors=3 | last4=Bertini | first4=E | last5=Boespflug-Tanguy | first5=O | last6=Cleveland | first6=DW |doi-access=free }}
*{{cite journal | author=Hand CK |title=Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis |journal=Arch. Neurol. |volume=60 |issue= 12 |pages= 1768–71 |year= 2004 |pmid= 14676054 |doi= 10.1001/archneur.60.12.1768 | name-list-style=vanc | author2=Devon RS | author3=Gros-Louis F | display-authors=3 | last4=Rochefort | first4=D | last5=Khoris | first5=J | last6=Meininger | first6=V | last7=Bouchard | first7=JP | last8=Camu | first8=W | last9=Hayden | first9=MR | doi-access=free }}
*{{cite journal | author=Hand CK |title=Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis |journal=Arch. Neurol. |volume=60 |issue= 12 |pages= 1768–71 |year= 2004 |pmid= 14676054 |doi= 10.1001/archneur.60.12.1768 | name-list-style=vanc | author2=Devon RS | author3=Gros-Louis F | display-authors=3 | last4=Rochefort | first4=D | last5=Khoris | first5=J | last6=Meininger | first6=V | last7=Bouchard | first7=JP | last8=Camu | first8=W | last9=Hayden | first9=MR | doi-access= }}
*{{cite journal | author=Ota T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 | name-list-style=vanc | author2=Suzuki Y | author3=Nishikawa T | display-authors=3 | last4=Otsuki | first4=Tetsuji | last5=Sugiyama | first5=Tomoyasu | last6=Irie | first6=Ryotaro | last7=Wakamatsu | first7=Ai | last8=Hayashi | first8=Koji | last9=Sato | first9=Hiroyuki | doi-access=free }}
*{{cite journal | author=Ota T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 | name-list-style=vanc | author2=Suzuki Y | author3=Nishikawa T | display-authors=3 | last4=Otsuki | first4=Tetsuji | last5=Sugiyama | first5=Tomoyasu | last6=Irie | first6=Ryotaro | last7=Wakamatsu | first7=Ai | last8=Hayashi | first8=Koji | last9=Sato | first9=Hiroyuki | doi-access=free }}
*{{cite journal | author=Kanekura K |title=Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants |journal=J. Biol. Chem. |volume=279 |issue= 18 |pages= 19247–56 |year= 2004 |pmid= 14970233 |doi= 10.1074/jbc.M313236200 | name-list-style=vanc | author2=Hashimoto Y | author3=Niikura T | display-authors=3 | last4=Aiso | first4=S | last5=Matsuoka | first5=M | last6=Nishimoto | first6=I | doi-access=free }}
*{{cite journal | author=Kanekura K |title=Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants |journal=J. Biol. Chem. |volume=279 |issue= 18 |pages= 19247–56 |year= 2004 |pmid= 14970233 |doi= 10.1074/jbc.M313236200 | name-list-style=vanc | author2=Hashimoto Y | author3=Niikura T | display-authors=3 | last4=Aiso | first4=S | last5=Matsuoka | first5=M | last6=Nishimoto | first6=I | doi-access=free }}
Line 34: Line 34:
*[https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=iahsp GeneReviews/NCBI/NIH/UW entry on ALS2-Related Disorders]
*[https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=iahsp GeneReviews/NCBI/NIH/UW entry on ALS2-Related Disorders]
* [https://www.ncbi.nlm.nih.gov/omim/205100,606352,606353,607225,205100,606352,606353,607225 OMIM entries on ALS2-Related Disorders]
* [https://www.ncbi.nlm.nih.gov/omim/205100,606352,606353,607225,205100,606352,606353,607225 OMIM entries on ALS2-Related Disorders]
*[http://ghr.nlm.nih.gov/gene/ALS2 Genetics Home Reference- US National Library of Medicine®]
*[http://ghr.nlm.nih.gov/gene/ALS2 Genetics Home Reference- US National Library of Medicine]
* {{UCSC gene info|ALS2}}
* {{UCSC gene info|ALS2}}



Latest revision as of 19:53, 19 April 2024

ALS2
Identifiers
AliasesALS2, ALS2CR6, ALSJ, IAHSP, PLSJ, alsin Rho guanine nucleotide exchange factor, alsin Rho guanine nucleotide exchange factor ALS2
External IDsOMIM: 606352; MGI: 1921268; HomoloGene: 23264; GeneCards: ALS2; OMA:ALS2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001135745
NM_020919

NM_001159948
NM_028717
NM_146109

RefSeq (protein)

NP_001129217
NP_065970

NP_001153420
NP_082993
NP_666221

Location (UCSC)Chr 2: 201.7 – 201.78 MbChr 1: 59.2 – 59.28 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Alsin is a protein that in humans is encoded by the ALS2 gene.[5][6] ALS2 orthologs[7] have been identified in all mammals for which complete genome data are available.

See also

[edit]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000003393Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000026024Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE (Oct 2001). "A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2". Nat Genet. 29 (2): 166–73. doi:10.1038/ng1001-166. PMID 11586298. S2CID 52828189.
  6. ^ "Entrez Gene: ALS2 amyotrophic lateral sclerosis 2 (juvenile)".
  7. ^ "OrthoMaM phylogenetic marker: ALS2 coding sequence". Archived from the original on 2016-03-04. Retrieved 2009-12-09.

Further reading

[edit]
[edit]